Singapore markets closed

Gilead Sciences, Inc. (0QYQ.IL)

IOB - IOB Delayed price. Currency in USD
Add to watchlist
69.80+2.29 (+3.38%)
At close: 07:14PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) 88.03B
Enterprise value 108.51B
Trailing P/E 193.89
Forward P/E 18.21
PEG ratio (5-yr expected) 0.87
Price/sales (ttm)3.19
Price/book (mrq)4.96
Enterprise value/revenue 3.95
Enterprise value/EBITDA 22.68

Trading information

Stock price history

Beta (5Y monthly) 0.35
52-week change 3-8.21%
S&P500 52-week change 326.24%
52-week high 387.53
52-week low 362.14
50-day moving average 365.80
200-day moving average 374.02

Share statistics

Avg vol (3-month) 333.31k
Avg vol (10-day) 3151.24k
Shares outstanding 51.25B
Implied shares outstanding 61.25B
Float 81.24B
% held by insiders 10.10%
% held by institutions 186.84%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 43
Forward annual dividend yield 43.81%
Trailing annual dividend rate 32.96
Trailing annual dividend yield 34.38%
5-year average dividend yield 43.91
Payout ratio 468.05%
Dividend date 3N/A
Ex-dividend date 414 Sept 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Jun 2023

Profitability

Profit margin 20.03%
Operating margin (ttm)35.75%

Management effectiveness

Return on assets (ttm)9.77%
Return on equity (ttm)26.35%

Income statement

Revenue (ttm)27.38B
Revenue per share (ttm)21.87
Quarterly revenue growth (yoy)5.40%
Gross profit (ttm)21.62B
EBITDA 12.16B
Net income avi to common (ttm)5.48B
Diluted EPS (ttm)4.35
Quarterly earnings growth (yoy)-8.70%

Balance sheet

Total cash (mrq)7.1B
Total cash per share (mrq)5.7
Total debt (mrq)25.25B
Total debt/equity (mrq)119.68%
Current ratio (mrq)1.02
Book value per share (mrq)16.97

Cash flow statement

Operating cash flow (ttm)9.51B
Levered free cash flow (ttm)9.62B